Figure 1.
Ratios of mono-oxidation metabolites 1 and 2 (M1 and M2) to atazanavir (ATV) concentration in 75 CYP3A5 expressers (n = 49) and non-expressers (n = 26). (a) Log10 M1/atazanavir ratios in expressers versus non-expressers. (b) Log10 M2/atazanavir ratios in expressers versus non-expressers.

Ratios of mono-oxidation metabolites 1 and 2 (M1 and M2) to atazanavir (ATV) concentration in 75 CYP3A5 expressers (n = 49) and non-expressers (n = 26). (a) Log10 M1/atazanavir ratios in expressers versus non-expressers. (b) Log10 M2/atazanavir ratios in expressers versus non-expressers.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close